Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC) | MicrobiomeTrials← Back to trialsNCT06988150
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-04-14Est. Completion: 2028-10-14
Enrollment target: 100 participants Locations- Cedars-Sinai Medical Center, Los Angeles, California, United States
Other microbiome trials you might be interested in
Pancreatic Carcinoma
This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic…
San Francisco, United StatesCompleted Oct 19, 2026
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
This study investigates the first-line treatment of advanced pancreatic cancer with KRAS G12D mutation. Patients were ra…
Shanghai, ChinaEst. completion Apr 2029
Recruiting
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035